PA
ASTH icon

Parallel Advisors’s Astrana Health ASTH Stock Holding History

Parallel Advisors’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.41K Sell
95
-12
-11% -$432 ﹤0.01% 3263
2026
Q1 		$2.62K Buy
+107
New +$2.53K ﹤0.01% 3281
2025
Q4 		– Sell
-41
Closed -$1.16K – 3774
2025
Q3 		$1.16K Buy
41
+14
+52% +$379 ﹤0.01% 3186
2025
Q2 		$672 Buy
+27
New +$760 ﹤0.01% 3266
2025
Q1 		– Sell
-70
Closed -$2.21K – 3694
2024
Q4 		$2.21K Buy
70
+46
+192% +$2.19K ﹤0.01% 2937
2024
Q3 		$1.39K Hold
24
– – ﹤0.01% 2968
2024
Q2 		$973 Buy
+24
New +$952 ﹤0.01% 2966
2021
Q4 		– Sell
-61
Closed -$6K – 3320
2021
Q3 		$6K Buy
61
+41
+205% +$3.49K ﹤0.01% 2310
2021
Q2 		$1K Hold
20
– – ﹤0.01% 2858
2021
Q1 		$1K Hold
20
– – ﹤0.01% 2718
2020
Q4 		$0 Buy
+20
New +$360 ﹤0.01% 2749

Other funds holding ASTH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Parallel Advisors's ASTH Position: Q2 2026 in Review

Parallel Advisors reduced its Astrana Health (ASTH) stake by 11% in Q2 2026, selling an estimated $432 and leaving 95 shares worth $4.41K. The position accounts for ﹤0.01% of the portfolio, ranked #3263.

Parallel Advisors first reported a position in ASTH in Q4 2020 and has held it in 11 quarters since. The position peaked at $6K in Q3 2021. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Parallel Advisors held 95 shares of Astrana Health worth $4.41K as of Q2 2026.
  • Parallel Advisors sold 12 Astrana Health shares in Q2 2026, an estimated $432.
  • Astrana Health made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3263 holding.
  • Parallel Advisors first reported a position in Astrana Health in Q4 2020 and has held it in 11 quarters since.
  • Parallel Advisors's Astrana Health position peaked at $6K in Q3 2021.
  • 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.